<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Progestogen-Only Contraception: Clinical Algorithm</title>
    <style>
        /* --- Google Font --- */
        @import url('https://fonts.googleapis.com/css2?family=Lato:wght@400;700&display=swap');

        /* --- Global Styles & Variables --- */
        :root {
            --primary-color: #005A9C; /* Professional Blue */
            --secondary-color: #f8f9fa; /* Light Grey Background */
            --text-color: #343a40; /* Dark Grey */
            --border-color: #dee2e6;
            --accent-color: #e77f00; /* Muted Orange for highlights */
            --card-shadow: 0 4px 15px rgba(0, 0, 0, 0.08);
            --border-radius: 8px;
        }

        body {
            font-family: 'Lato', sans-serif;
            margin: 0;
            padding: 0;
            background-color: var(--secondary-color);
            color: var(--text-color);
            line-height: 1.6;
        }

        /* --- Layout & Container --- */
        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 20px;
        }

        /* --- Header --- */
        .header {
            text-align: center;
            padding: 30px 20px;
            background-color: #ffffff;
            border-bottom: 1px solid var(--border-color);
            margin-bottom: 30px;
        }

        .header h1 {
            color: var(--primary-color);
            font-size: 2.5em;
            margin: 0;
        }

        .header p {
            font-size: 1.1em;
            color: #6c757d;
            margin-top: 5px;
        }

        /* --- Section & Card Styles --- */
        .section {
            background-color: #ffffff;
            margin-bottom: 30px;
            padding: 25px 30px;
            border-radius: var(--border-radius);
            box-shadow: var(--card-shadow);
        }

        .section h2 {
            font-size: 1.8em;
            color: var(--primary-color);
            border-bottom: 2px solid var(--primary-color);
            padding-bottom: 10px;
            margin-top: 0;
            margin-bottom: 25px;
        }

        /* --- Responsive Table --- */
        .table-container {
            overflow-x: auto;
        }
        
        .responsive-table {
            width: 100%;
            border-collapse: collapse;
            margin-bottom: 1em;
        }

        .responsive-table th, .responsive-table td {
            padding: 15px;
            text-align: left;
            border-bottom: 1px solid var(--border-color);
        }

        .responsive-table th {
            background-color: #f1f3f5;
            font-weight: 700;
        }

        .responsive-table tbody tr:hover {
            background-color: #f8f9fa;
        }
        
        .responsive-table strong {
            color: var(--primary-color);
        }

        /* --- Managing Problems Section --- */
        .problem-cards {
            display: grid;
            gap: 25px;
            grid-template-columns: 1fr; /* Default for mobile */
        }
        
        .problem-card {
            border: 1px solid var(--border-color);
            border-radius: var(--border-radius);
            padding: 20px;
            background-color: #fdfdfd;
        }

        .problem-card h3 {
            display: flex;
            align-items: center;
            font-size: 1.4em;
            margin-top: 0;
            color: var(--primary-color);
        }
        
        .problem-card h3 svg {
            margin-right: 12px;
            fill: var(--primary-color);
        }

        .problem-card ol {
            padding-left: 20px;
        }
        
        .problem-card li::marker {
            font-weight: 700;
            color: var(--primary-color);
        }

        .highlight-time {
            font-weight: 700;
            background-color: #fff3cd;
            color: #856404;
            padding: 3px 6px;
            border-radius: 4px;
        }
        
        /* --- Drug Interactions --- */
        .interactions {
            background-color: #fff9e6;
            border-left: 5px solid var(--accent-color);
            padding: 20px;
            border-radius: var(--border-radius);
        }
        .interactions p {
            margin: 0;
        }

        /* --- Footer --- */
        .footer {
            text-align: center;
            padding: 20px;
            font-size: 0.9em;
            color: #6c757d;
        }
        
        /* --- Media Queries for Responsiveness --- */
        @media (min-width: 768px) {
            .problem-cards {
                grid-template-columns: repeat(2, 1fr);
            }
        }
        @media (min-width: 992px) {
            .problem-cards {
                grid-template-columns: repeat(3, 1fr);
            }
        }

        @media (max-width: 600px) {
            .header h1 {
                font-size: 2em;
            }
            .section {
                padding: 20px;
            }
            .section h2 {
                font-size: 1.5em;
            }
            .responsive-table th, .responsive-table td {
                padding: 10px;
            }
        }
    </style>
</head>
<body>

    <header class="header">
        <h1>Progestogen-Only Contraception</h1>
        <p>A Quick Reference Clinical Algorithm</p>
    </header>

    <main class="container">
        
        <!-- Section 1: Method Selection -->
        <section class="section">
            <h2>1. Method Selection & Key Considerations</h2>
            <div class="table-container">
                <table class="responsive-table">
                    <thead>
                        <tr>
                            <th>Method</th>
                            <th>Types Available</th>
                            <th>Key Advantages</th>
                            <th>Key Disadvantages & Cautions</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Progestogen-Only Pill (POP)</strong></td>
                            <td><strong>Traditional:</strong> Norethisterone, Levonorgestrel<br><strong>Desogestrel</strong> (12hr window)<br><strong>Drospirenone</strong> (24hr window)</td>
                            <td>Suitable when oestrogen is contraindicated. Good for high BMI, smokers >35, migraine with aura.</td>
                            <td>Daily adherence required. Unscheduled bleeding common. Efficacy reduced by enzyme-inducing drugs.</td>
                        </tr>
                        <tr>
                            <td><strong>Progestogen-Only Implant</strong></td>
                            <td>Etonogestrel 68 mg (Nexplanon®)</td>
                            <td>Highly effective (>99%). "Fit and forget" for 3 years.</td>
                            <td>Requires trained professional for insertion/removal. Unscheduled bleeding common. Efficacy reduced by enzyme-inducing drugs.</td>
                        </tr>
                        <tr>
                            <td><strong>Progestogen-Only Injectable</strong></td>
                            <td>Depot medroxyprogesterone acetate (DMPA) - <em>Depo-Provera® / Sayana Press®</em></td>
                            <td>Given every 13 weeks. Not affected by enzyme-inducing drugs.</td>
                            <td>Delayed return to fertility (up to 1 year). Potential weight gain. Small, reversible loss of bone mineral density. <strong>Review use every 2 years.</strong></td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </section>

        <!-- Section 2: Initial Assessment & Starting -->
        <section class="section">
            <h2>2. Initial Assessment & Starting Contraception</h2>
            <div class="table-container">
                <table class="responsive-table">
                    <thead>
                        <tr>
                            <th>Patient Situation</th>
                            <th>When to Start</th>
                            <th>Additional Precautions Needed?</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>During Menstrual Cycle (Days 1-5)</strong></td>
                            <td>Start <strong>immediately</strong></td>
                            <td><strong>No</strong></td>
                        </tr>
                        <tr>
                            <td><strong>During Menstrual Cycle (After Day 5)</strong></td>
                            <td>Start <strong>immediately</strong> (if pregnancy excluded)</td>
                            <td><strong>Yes.</strong> Use condoms for:<br>• <strong>2 days</strong> (Traditional/Desogestrel POP)<br>• <strong>7 days</strong> (Drospirenone POP / Implant / Injectable)</td>
                        </tr>
                        <tr>
                            <td><strong>Postpartum (&lt;21 days)</strong></td>
                            <td>Start <strong>any time</strong></td>
                            <td><strong>No</strong></td>
                        </tr>
                        <tr>
                            <td><strong>Postpartum (&gt;21 days) or Amenorrhoeic</strong></td>
                            <td>Start <strong>any time</strong> (if pregnancy excluded)</td>
                            <td><strong>Yes.</strong> Use condoms for the duration listed above.</td>
                        </tr>
                        <tr>
                            <td><strong>After EC (Levonorgestrel)</strong></td>
                            <td>Start <strong>immediately</strong></td>
                            <td><strong>Yes.</strong> Use condoms and advise pregnancy test in 3 weeks.</td>
                        </tr>
                        <tr>
                            <td><strong>After EC (Ulipristal Acetate)</strong></td>
                            <td><strong>Wait 5 days</strong> before starting</td>
                            <td><strong>Yes.</strong> Use condoms and advise pregnancy test in 3 weeks.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </section>

        <!-- Section 3: Switching Methods -->
        <section class="section">
            <h2>3. Switching Between Methods</h2>
            <div class="table-container">
                <table class="responsive-table">
                    <thead>
                        <tr>
                            <th>Switching FROM...</th>
                            <th>Instructions</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Combined Hormonal Contraception (CHC)</strong></td>
                            <td><strong>Start on Day 1-2 of hormone-free interval.</strong> No extra precautions needed. If starting later, use condoms for 7 days.</td>
                        </tr>
                        <tr>
                            <td><strong>Another POP</strong></td>
                            <td><strong>Start immediately.</strong> No pill-free gap. Use condoms for <strong>7 days</strong> if switching <strong>TO Drospirenone</strong>.</td>
                        </tr>
                        <tr>
                            <td><strong>Implant / IUS / Injectable</strong></td>
                            <td><strong>Start on the day of removal or when next dose is due.</strong> No extra precautions needed.</td>
                        </tr>
                        <tr>
                            <td><strong>Copper IUD</strong></td>
                            <td><strong>If Day 1-5 of cycle:</strong> Remove IUD and start. No extra precautions.<br><strong>If after Day 5:</strong> Start method, use condoms for 7 days, and remove IUD 7 days later.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </section>
        
        <!-- Section 4: Managing Common Problems -->
        <section class="section">
            <h2>4. Managing Common Problems</h2>
            <div class="problem-cards">
                <div class="problem-card">
                    <h3>
                        <svg xmlns="http://www.w3.org/2000/svg" height="24px" viewBox="0 0 24 24" width="24px"><path d="M0 0h24v24H0V0z" fill="none"/><path d="M11.99 2C6.47 2 2 6.48 2 12s4.47 10 9.99 10C17.52 22 22 17.52 22 12S17.52 2 11.99 2zM12 20c-4.42 0-8-3.58-8-8s3.58-8 8-8 8 3.58 8 8-3.58 8-8 8zm.5-13H11v6l5.25 3.15.75-1.23-4.5-2.67z"/></svg>
                        Missed Progestogen-Only Pill (POP)
                    </h3>
                    <ol>
                        <li><strong>Identify Time Window:</strong><br>
                            • Traditional POP: <span class="highlight-time">&gt; 3 hours late</span><br>
                            • Desogestrel POP: <span class="highlight-time">&gt; 12 hours late</span><br>
                            • Drospirenone POP: <span class="highlight-time">&gt; 24 hours late</span>
                        </li>
                        <li><strong>Take pill ASAP</strong> (even if two in one day).</li>
                        <li>Continue subsequent pills at usual time.</li>
                        <li><strong>Use condoms</strong> for <strong>2 days</strong> (Trad/Desogestrel) or <strong>7 days</strong> (Drospirenone).</li>
                        <li>Consider EC if unprotected sex occurred.</li>
                    </ol>
                </div>
                <div class="problem-card">
                    <h3>
                        <svg xmlns="http://www.w3.org/2000/svg" height="24px" viewBox="0 0 24 24" width="24px"><path d="M0 0h24v24H0z" fill="none"/><path d="M17.5 2.5c-1.13 0-2.16.39-3 1.02-1.63-1.68-4.37-1.74-6.08-.13-1.71 1.61-1.77 4.35-.15 6.08L12 21.01l3.73-3.54.01-.01c.23-.22.45-.46.65-.71 1.63-1.68 1.57-4.42-.15-6.08-.84-.78-1.87-1.17-3-1.17zM12 18.59l-3.26-3.09c-.8-.76-.85-2.06-.1-2.85.76-.8 2.06-.85 2.85-.1l.51.46.51-.46c.8-.76 2.09-.71 2.85.1.75.79.7 2.09-.1 2.85L12 18.59z"/></svg>
                        Unscheduled Bleeding
                    </h3>
                    <ol>
                        <li><strong>Exclude Pathology:</strong> Screen for STIs, perform pregnancy test, consider speculum exam if indicated.</li>
                        <li><strong>Reassure:</strong> Explain this is common, especially in the first 3 months, and often settles.</li>
                        <li><strong>Treat (if unacceptable):</strong><br>• Mefenamic Acid 500mg TDS for 5 days.<br>• Trial a 3-month course of a COC.<br>• Consider switching methods if persistent.</li>
                    </ol>
                </div>
                <div class="problem-card">
                    <h3>
                        <svg xmlns="http://www.w3.org/2000/svg" height="24px" viewBox="0 0 24 24" width="24px"><path d="M0 0h24v24H0V0z" fill="none"/><path d="M21 3H3c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h18c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zm-9 15c-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5-2.24 5-5 5zm0-8c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
                        Late Injectable (DMPA)
                    </h3>
                    <ol>
                        <li><strong>If &lt; 14 weeks since last injection:</strong> Give injection. No further action needed.</li>
                        <li><strong>If &gt; 14 weeks since last injection:</strong>
                            <br>• <strong>No UPSI:</strong> Give injection. Advise condoms for 7 days.
                            <br>• <strong>Yes, UPSI:</strong> Assess need for EC. Give injection. Advise condoms for 7 days and pregnancy test in 3 weeks.
                        </li>
                    </ol>
                </div>
            </div>
        </section>

        <!-- Section 5: Drug Interactions -->
        <section class="section">
            <h2>5. Key Drug Interactions</h2>
            <div class="interactions">
                <p><strong>Enzyme-Inducing Drugs</strong> (e.g., Carbamazepine, Phenytoin, Rifampicin, St. John's Wort) <strong>significantly reduce the efficacy of POPs and the Implant.</strong> Advise switching to an unaffected method (DMPA injectable, IUD/IUS) or using consistent barrier protection.</p>
            </div>
        </section>

    </main>

    <footer class="footer">
        <p>This is a summary for rapid reference and does not replace full clinical guidelines or professional judgment. Based on NICE CKS guidance.</p>
    </footer>

</body>
</html>